| Dr Lauren Kershnar, MD | |
|
1000 Houghton Ave, Saginaw, MI 48602-5303 | |
| (989) 583-6817 | |
| Not Available |
| Full Name | Dr Lauren Kershnar |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1000 Houghton Ave, Saginaw, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124408331 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4301107841 (Michigan) | Primary |
| Entity Name | Barron Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790736940 PECOS PAC ID: 8820083785 Enrollment ID: O20040419001416 |
News Archive
CAR-T biotherapeutics company Carina Biotech and researchers at the University of South Australia have developed a novel approach based on microfluidic technology to "purify" the immune cells of patients in the fight against cancer.
The New York Times: "In a day of desultory debate on sweeping health care legislation, senators appealed to two potent political constituencies ... with Democrats seeking additional medical benefits for women and Republicans vowing to preserve and protect Medicare for older Americans. The Democrats' first amendment, offered by Senator Barbara A. Mikulski of Maryland, would require insurers to cover more screenings and preventive care for women, with no co-payments."
UCLA/VA scientists have identified a new gene that controls how the body produces and uses fat. Called lipin, the gene may provide a new target for therapies to control obesity, diabetes and other weight-related disorders. The first issue of the new journal Cell Metabolism publishes the findings in its January 2005 edition.
It's never too early for you to start taking care of your heart.
Amgen today announced positive results from several new analyses of two Phase 3 trials studying denosumab compared with Zometa® (zoledronic acid), the current standard of care, for the treatment of bone metastases in patients with advanced breast cancer ("136 study") and solid tumors or multiple myeloma ("244 study"). Results from these trials reinforce denosumab's consistent ability to delay the complications of bone metastases in patients with advanced cancer. These results are being presented during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lauren Kershnar, MD 1000 Houghton Ave, Saginaw, MI 48602-5303 Ph: (989) 583-6817 | Dr Lauren Kershnar, MD 1000 Houghton Ave, Saginaw, MI 48602-5303 Ph: (989) 583-6817 |
News Archive
CAR-T biotherapeutics company Carina Biotech and researchers at the University of South Australia have developed a novel approach based on microfluidic technology to "purify" the immune cells of patients in the fight against cancer.
The New York Times: "In a day of desultory debate on sweeping health care legislation, senators appealed to two potent political constituencies ... with Democrats seeking additional medical benefits for women and Republicans vowing to preserve and protect Medicare for older Americans. The Democrats' first amendment, offered by Senator Barbara A. Mikulski of Maryland, would require insurers to cover more screenings and preventive care for women, with no co-payments."
UCLA/VA scientists have identified a new gene that controls how the body produces and uses fat. Called lipin, the gene may provide a new target for therapies to control obesity, diabetes and other weight-related disorders. The first issue of the new journal Cell Metabolism publishes the findings in its January 2005 edition.
It's never too early for you to start taking care of your heart.
Amgen today announced positive results from several new analyses of two Phase 3 trials studying denosumab compared with Zometa® (zoledronic acid), the current standard of care, for the treatment of bone metastases in patients with advanced breast cancer ("136 study") and solid tumors or multiple myeloma ("244 study"). Results from these trials reinforce denosumab's consistent ability to delay the complications of bone metastases in patients with advanced cancer. These results are being presented during the 2010 American Society of Clinical Oncology Annual Meeting in Chicago.
› Verified 6 days ago
Dr. Meagan Crofoot, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-583-6800 | |
Andrew Michael Franklin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 S Washington Ave, Saginaw, MI 48601 Phone: 989-793-7220 Fax: 989-793-7482 | |
Mrs. Jayme Kern Hall, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Cooper Ave, Saginaw, MI 48602 Phone: 989-583-6521 | |
Michael Andrew Salvatore Cannova, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 Houghton Ave, Saginaw, MI 48602 Phone: 989-746-7518 | |
Charles Hooshmand Nightingale, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 S Washington Ave, Saginaw, MI 48601 Phone: 989-907-8200 Fax: 989-907-8294 | |
Dr. Derek Schaller, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Cooper Ave, Saginaw, MI 48602 Phone: 989-583-6521 | |
Dr. Barbie Jean Fernelius, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 900 Cooper Ave, Saginaw, MI 48602 Phone: 989-583-6521 |